CEO’s Message

Hello readers, I want to welcome you as we return “to the world as we know it”. With the removal of restrictions on public gatherings, the lifting of the nationwide curfews, relaxed face mask restrictions and the relaxed domestic and international travel guidelines, it’s safe to say corona season is over! As we strive to forge ahead as a collective and build on the ruins of the pandemic, let’s endeavour to get the complete course of vaccination and keep up with public health guidelines and safety advisory. I am also super excited and proud to welcome you to the maiden edition of our newsletter. This is something we’ve had in the works for a while. Rest assured, this is the first of many series, as we intend to make quarterly releases. As our premier subscriber, a gift is hidden somewhere in this letter, but you would need to read along to find it. The recent past years have been challenging since the sudden onset of the covid-19 pandemic, disrupting life as we know it, and its crippling economic effects were felt by businesses across the globe on either spectrum of revenue scale, be you a Fortune 500 corporation or MSME, no surprise we weren’t insulated from these effects. Well, as the popular saying goes, the darkest hour is just before dawn. Over the years, our story has been one of resilience, invention and innovation. Being a brainchild of two industry leaders (our parent companies) we consolidated on our advantage of industry knowledge and insights and at this particular dawn, we emerged as a lean and agile health tech startup. To get the inside scoop, look out for our feature story – Genesys: The rise and rebirth

Following our rebirth, we have been able to streamline our products, introducing three new variants; GeneSys Lite, GeneSys Midi & GeneSys ERP. The Lite & Midi are EMR variants geared towards primary and secondary care, while the ERP is our bespoke enterprise offering. It is a custom-built Hospital Management Information System. We are barely weeks away from introducing our revolutionary GeneSys v2 release. This is a culmination of nearly a decade of industry experience, insights and feedback, layered on modern technologies and software design principles. It has taken about 3-years to develop, however, I am pleased to announce that it would be available to the market before Q3 2022.

This newsletter is intended to be a compendium of topics across the spectrum of health and tech and features a recap of our Twitter space event from the previous quarter, titled – Regulating the health tech Space and our just concluded webinar titled Healthcare Cybersecurity: Protecting patient information. We have meticulously and thoughtfully curated a lineup of trending health and techrelated topics that would be sure to pique your curiosity and keep you engaged, so sit back, put your feet up, relax and enjoy the read .

If you’ve gotten this far, then you deserve the gift. We have limited advertisement slots, which we would be giving out for free within the next issue of our publication. To be eligible, simply send an email with your product offering to editorial@ genesys-health.com with the subject, free advert.

All the best,

Ayo-Olagunju Muna

CEO Genesys Health